Results 51 to 60 of about 732,506 (308)

HE4 in the differential diagnosis of ovarian masses [PDF]

, 2015
Ovarian masses, a common finding among pre- and post-menopausal women, can be benign or malignant. Ovarian cancer is the leading cause of death from gynecologic malignancy among women living in industrialized countries.
ANASTASI, Emanuela, ANGELONI, Antonio, Flavia Longo, MANGANARO, Lucia, PORPORA, Maria Grazia, Teresa Granato   +5 more
core   +1 more source

Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition

Frontiers in Immunology, 2022
The development and implementation of Immune Checkpoint Inhibitors (ICI) in clinical oncology have significantly improved the survival of a subset of cancer patients with metastatic disease previously considered uniformly lethal.
Agnete S. T. Engelsen, Maria L. Lotsberg, Raefa Abou Khouzam, Jean-Paul Thiery, Jean-Paul Thiery, Jean-Paul Thiery, James B. Lorens, Salem Chouaib, Salem Chouaib, Salem Chouaib, Salem Chouaib, Stéphane Terry, Stéphane Terry, Stéphane Terry, Stéphane Terry   +14 more
doaj   +1 more source

Identification and validation of oncologic miRNA biomarkers for Luminal A-like breast cancer [PDF]

, 2014
Introduction: Breast cancer is a common disease with distinct tumor subtypes phenotypically characterized by ER and HER2/neu receptor status. MiRNAs play regulatory roles in tumor initiation and progression, and altered miRNA expression has been ...
A Weissmann-Brenner, Ailbhe M. McDermott, AJ Huang, Alessandro Weisz, BS Li, C Blenkiron, CG Moertel, Deirdre Wall, F Mar-Aguilar, Graham Ball, H Zhao, HM Heneghan, I Jacobs, IM Thompson, J Nishimura, Karl J. Sweeney, KH Shin, LJ Guo, LJ Lancashire, Lorcan M. Martyn, M Ferracin, M Mittelbrunn, M Yang, Michael J. Kerin, MV Iorio, Network Cancer Genome Atlas, Nicola Miller, PA Davoren, PS Waters, S Yang, SA Eccles, SD Bhattacharya, SF Hausler, W Gao, X Zeng, Y Endo, Y Lin   +36 more
core   +3 more sources

Biomarkers for patients with Wilms tumor: a review

Frontiers in Oncology, 2023
Wilms tumor, originating from aberrant fetal nephrogenesis, is the most common renal malignancy in childhood. The overall survival of children is approximately 90%. Although existing risk-stratification systems are helpful in identifying patients with poor prognosis, the recurrence rate of Wilms tumors remains as high as 15%.
Hongfeng Zheng, Jiangui Liu, Xiuwu Pan, Xingang Cui   +3 more
openaire   +3 more sources

Plasma IgG and IgM autoantibodies to COPT1 as potential biomarkers for detection of non-small cell lung cancer

Frontiers in Immunology
BackgroundEarly diagnosis of lung cancer is crucial for improving patient outcomes. Autoantibodies against tumor-associated antigens (TAAs) found in the plasma can serve as biomarkers for lung cancer detection.
Xiaobin Cao, Xiaobin Cao, Jing Li, Siyu Liu, Siyu Liu, Aichen Liu, Lulu Zhang, Fengqi Chen, Yutong Li, Yutong Li, Hanke Ma, Wenke Sun, Songyun Ouyang, Liping Dai, Jingjing Liu   +14 more
doaj   +1 more source

The association between CTSZ methylation in peripheral blood and breast cancer in Chinese women

Frontiers in Oncology, 2023
PurposePrevious studies have shown that DNA methylation in peripheral blood may be associated with breast cancer (BC). To explore the association between the methylation level of the Cathepsin Z (CTSZ) gene in peripheral blood and BC, we conducted a case–
Jinyu Li, Xiajie Zhou, Lixi Li, Longtao Ji, Longtao Ji, Jiaqi Li, Yunhui Qu, Zhi Wang, Zhi Wang, Yutong Zhao, Jie Zhang, Feifei Liang, Feifei Liang, Jingjing Liu, Wanjian Gu, Rongxi Yang, Fei Ma, Liping Dai, Liping Dai   +18 more
doaj   +1 more source

Evaluation of MMP‑2, MMP‑9, TIMP‑1, TIMP‑2, NGAL and MMP‑9/NGAL complex in urine and sera from patients with bladder cancer [PDF]

, 2015
The identification of biomarkers in urine or serum samples from patients with bladder cancer is urgently required for the development of non-invasive methods for the diagnosis of bladder carcinoma and to facilitate follow-up surveillance, to combat the ...
Bruzzese, Dario, DI CARLO, Angelina, Ricci, Serena   +2 more
core   +1 more source

The Role of CTCs as Tumor Biomarkers

, 2015
Detection of Circulating Tumor Cells (CTCs) in peripheral blood can serve as a "liquid biopsy" approach and as a source of valuable tumor markers. CTCs are rare, and thus their detection, enumeration and molecular characterization are very challenging.
Lianidou, E.S., Markou, A., Strati, A.
openaire   +3 more sources

Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI

Scientific Reports, 2022
This study aimed to differentiate isocitrate dehydrogenase (IDH) mutation status with the voxel-wise clustering method of multiparametric magnetic resonance imaging (MRI) and to discover biological underpinnings of the clusters.
Akifumi Hagiwara, Hiroyuki Tatekawa, Jingwen Yao, Catalina Raymond, Richard Everson, Kunal Patel, Sergey Mareninov, William H. Yong, Noriko Salamon, Whitney B. Pope, Phioanh L. Nghiemphu, Linda M. Liau, Timothy F. Cloughesy, Benjamin M. Ellingson   +13 more
doaj   +1 more source

The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer. [PDF]

, 2014
The focus of this review is to provide an update on the progress of microRNAs (miRNAs) as potential biomarkers for lung cancer. miRNAs are single-stranded, small non-coding RNAs that regulate gene expression and show tissue-specific signatures ...
Haisheng eXu, Wenbin eDeng, Wenbin eDeng, Wenrong eGong, Xin eQin   +4 more
core   +2 more sources